Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 3
2004 2
2005 2
2007 1
2008 1
2009 1
2010 1
2011 1
2023 2
2024 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
PCM4EU and PRIME-ROSE: Collaboration for implementation of precision cancer medicine in Europe.
Taskén K, F Haj Mohammad S, Fagereng GL, Sørum Falk R, Helland Å, Barjesteh van Waalwijk van Doorn-Khosrovani S, Steen Carlsson K, Ryll B, Jalkanen K, Edsjö A, Russnes HG, Lassen U, Hallersjö Hult E, Lugowska I, Blay JY, Verlingue L, Abel E, Lowery MA, Krebs MG, Staal Rohrberg K, Ojamaa K, Oliveira J, Verheul HMW, Voest EE, Gelderblom H; PRIME-ROSE Consortium and the PCM4EU Consortium. Taskén K, et al. Among authors: barjesteh van waalwijk van doorn khosrovani s. Acta Oncol. 2024 May 23;63:385-391. doi: 10.2340/1651-226X.2024.34791. Acta Oncol. 2024. PMID: 38779910 Free PMC article.
Interchangeability of immune checkpoint inhibitors: an urgent need for action.
Zietse M, van Leeuwen RWF, Barjesteh van Waalwijk van Doorn-Khosrovani S, de Boer JE, Dupree R, Mathijssen RHJ, Timmers L. Zietse M, et al. Among authors: barjesteh van waalwijk van doorn khosrovani s. Lancet Oncol. 2024 Nov;25(11):e611-e616. doi: 10.1016/S1470-2045(24)00212-2. Epub 2024 Oct 14. Lancet Oncol. 2024. PMID: 39419062 Review.
Cemiplimab in locally advanced or metastatic cutaneous squamous cell carcinoma: prospective real-world data from the DRUG Access Protocol.
Verkerk K, Geurts BS, Zeverijn LJ, van der Noort V, Verheul HMW, Haanen JBAG, van der Veldt AAM, Eskens FALM, Aarts MJB, van Herpen CML, Jalving M, Gietema JA, Devriese LA, Labots M, Barjesteh van Waalwijk van Doorn-Khosrovani S, Smit EF, Bloemendal HJ. Verkerk K, et al. Among authors: barjesteh van waalwijk van doorn khosrovani s. Lancet Reg Health Eur. 2024 Mar 5;39:100875. doi: 10.1016/j.lanepe.2024.100875. eCollection 2024 Apr. Lancet Reg Health Eur. 2024. PMID: 38464480 Free PMC article.
Editorial: Towards continued and affordable accessibility of innovative drugs: sustainable development and efficient use of medicines.
Huisman AH, van den Berg D, de Visser S, Ryll B, Barjesteh van Waalwijk van Doorn-Khosrovani S. Huisman AH, et al. Among authors: barjesteh van waalwijk van doorn khosrovani s. Front Pharmacol. 2024 Nov 5;15:1490853. doi: 10.3389/fphar.2024.1490853. eCollection 2024. Front Pharmacol. 2024. PMID: 39564106 Free PMC article. No abstract available.
Histology independent drug development - Is this the future for cancer drugs?
Billingham L, Brown L, Framke T, Greystoke A, Hovig E, Mathur S, Page P, Pean E, Barjesteh van Waalwijk van Doorn-Khosrovani S, Vonk R, Wissink S, Zander H, Plummer R. Billingham L, et al. Among authors: barjesteh van waalwijk van doorn khosrovani s. Cancer Treat Rev. 2024 Feb;123:102674. doi: 10.1016/j.ctrv.2023.102674. Epub 2023 Dec 23. Cancer Treat Rev. 2024. PMID: 38176220 Free article. Review.
Etoposide-initiated MLL rearrangements: the pitfalls of inverse PCR.
Barjesteh van Waalwijk van Doorn-Khosrovani S, Vanhees K, Ruijters E, van Schooten FJ. Barjesteh van Waalwijk van Doorn-Khosrovani S, et al. Eur J Haematol. 2008 Dec;81(6):486-8. doi: 10.1111/j.1600-0609.2008.01147.x. Eur J Haematol. 2008. PMID: 18774953 No abstract available.
The role of estrogenic compounds in the etiology of pediatric leukemia.
Vanhees K, de Bock L, van Schooten FJ, Barjesteh van Waalwijk van Doorn-Khosrovani S. Vanhees K, et al. Among authors: barjesteh van waalwijk van doorn khosrovani s. Leuk Res. 2009 Nov;33(11):e210-1. doi: 10.1016/j.leukres.2009.06.008. Epub 2009 Jul 4. Leuk Res. 2009. PMID: 19577806 No abstract available.
Prognostically useful gene-expression profiles in acute myeloid leukemia.
Valk PJ, Verhaak RG, Beijen MA, Erpelinck CA, Barjesteh van Waalwijk van Doorn-Khosrovani S, Boer JM, Beverloo HB, Moorhouse MJ, van der Spek PJ, Löwenberg B, Delwel R. Valk PJ, et al. Among authors: barjesteh van waalwijk van doorn khosrovani s. N Engl J Med. 2004 Apr 15;350(16):1617-28. doi: 10.1056/NEJMoa040465. N Engl J Med. 2004. PMID: 15084694 Free article.
17 results